Oral dosage form comprising rosiglitazone

Details for Australian Patent Application No. 2006210135 (hide)

Owner SB Pharmco Puerto Rico Inc.

Inventors Re, Vincenzo

Agent Davies Collison Cave

Pub. Number AU-A-2006210135

PCT Pub. Number WO2006/082089

Priority 0502479.9 07.02.05 GB

Filing date 3 February 2006

Wipo publication date 10 August 2006

International Classifications

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/082089 Priority application(s): WO2006/082089

9 October 2008 Assignment before Grant

  SB Pharmco Puerto Rico Inc. The application has been assigned to SmithKline Beecham (Cork) Limited

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006210140-Knowledge discovery tool extraction and integration

2006210126-Powder coatings